Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.
75N98026Q00392 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A GENERAL MEDICAL AND SURGICAL HOSPITALS solicitation, performed in Bethesda, MD, with responses due 2026-06-03. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Attachment: Notice of Intent to Sole Source
Comparable recent awards in GENERAL MEDICAL AND SURGICAL HOSPITALS
| Winner | Award value | Offers | Date |
|---|---|---|---|
| TMA LASER GROUP INC | $435K | n/a | 2026-06-30 |
| BOSTON SCIENTIFIC CORP | $23K | 1 | 2026-06-29 |
| TMA LASER GROUP INC | $900K | 1 | 2026-06-24 |
| TMA LASER GROUP INC | $174K | n/a | 2026-06-24 |
| WELLPATH LLC | $22K | 1 | 2026-06-18 |
Questions
What is solicitation 75N98026Q00392?
Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients., issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 622110 (GENERAL MEDICAL AND SURGICAL HOSPITALS), performed in Bethesda, MD. Responses are due 2026-06-03.
What do similar contracts close for?
Comparable closed awards in this category ran from $22K to $900K, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is 75N98026Q00392 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.